The annoucement comes as the health service plans to expand its lifesaving screen programme to 50-year-olds in England ... of bowel cancer. This move is the latest step in NHS goals to find ...

Manchester University NHS ... England, creating a standardised and efficient dermatology pathway.” Earlier this year, the US Food and Drug Administration (FDA) greenlit DermaSensor’s skin ...

We’re pleased this additional treatment option at this stage in the pathway could be a valuable alternative choice for patients and clinicians Claire Rowney, Breast Cancer Now It said evidence ...

CEO of Bayer UK & Ireland, Antonio Payano, said: “We are delighted that men with prostate cancer in England will have early access to another innovative treatment option. It’s vital that NHS ...